ABBVIE THERAPEUTICS INDIA PRIVATE LIMITED

Nature of Business: Trader (Marketer and Distributor)

Company Introduction:

ABBVIE THERAPEUTICS INDIA PRIVATE LIMITED is the Indian subsidiary of AbbVie Inc., a leading global biopharmaceutical company. In India, its core operations revolve around the marketing, sale, and distribution of AbbVie's innovative pharmaceutical products. These products are typically developed and manufactured by AbbVie's global facilities outside of India and then imported for commercialization within the Indian market. The company is dedicated to providing advanced therapies to patients in various therapeutic areas, including immunology, oncology, neuroscience, and virology. While engaged in commercial activities and clinical trials in India, it does not function as a manufacturing factory in the traditional sense. Its primary role is to ensure access to AbbVie's global portfolio for Indian healthcare professionals and patients.

ABBVIE THERAPEUTICS INDIA PRIVATE LIMITED manufactures and/or markets the following products in India:

* HUMIRA (adalimumab)

* VIEKIRA PAK (ombitasvir/paritaprevir/ritonavir tablets; dasabuvir tablets)

* MAVYRET (glecaprevir/pibrentasvir)

* DUOPA (carbidopa and levodopa)

* CREON (pancreatin)

* BOTOX (onabotulinumtoxinA)

* JUVEDERM (various hyaluronic acid dermal fillers)

* ORILISSA (elagolix)

* RINVOQ (upadacitinib)

* SKYRIZI (risankizumab)

This list may not be exhaustive and could change over time.